SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Pacemaker Implantation following Heart Transplantation: Analysis of a Nation-Wide Database.

Doulamis, IP; Wu, B; Akbar, AF; Xanthopoulos, A; Androulakis, E; Briasoulis, A (2023) Pacemaker Implantation following Heart Transplantation: Analysis of a Nation-Wide Database. J Clin Med, 12 (4). p. 1604. ISSN 2077-0383 https://doi.org/10.3390/jcm12041604
SGUL Authors: Androulakis, Emmanouil

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

BACKGROUND: The 2018 United-Network-for-Organ-Sharing (UNOS) allocation-system changes resulted in greater recognition of mechanical circulatory support (MCS), leading to more heart transplantations (HTx) in patients with MCS. We aimed to investigate the effect of the new UNOS allocation system on the need for a permanent pacemaker and associated complications following HTx. METHODS: The UNOS Registry was questioned, to identify patients that received HTx in the US between 2000 and 2021. The primary objectives were to identify risk factors for the need for a pacemaker implantation following HTx. RESULTS: 49,529 HTx patients were identified, 1421 (2.9%) requiring a pacemaker post-HTx. Patients who required a pacemaker were older (53.9 ± 11.5 vs. 52.6 ± 12.8 years, p < 0.001), more frequently white (73% vs. 67%; p < 0.001) and less frequently black (18% vs. 20%; p < 0.001). In the pacemaker group, UNOS status 1A (46% vs. 41%; p < 0.001) and 1B (31% vs. 27%; p < 0.001) were more prevalent, and donor age was higher (34.4 ± 12.4 vs. 31.8 ± 11.5 years; p < 0.001). One-year survival was no different between the groups (HR: 1.08; 95% CI: 0.85, 1.37; p = 0.515). An era effect was observed (per year: OR: 0.97; 95% CI: 0.96, 0.98; p = 0.003), while ECMO pre-transplant was associated with lower risk of a pacemaker (OR: 0.41; 95% CI: 0.19, 0.86; p < 0.001). CONCLUSIONS: While associated with various patient and transplant characteristics, pacemaker implantation does not seem to impact one-year survival after HTx. The need for pacemaker implantation was lower in the more recent era and in patients who required ECMO pre-transplant, a finding explained by recent advances in perioperative care.

Item Type: Article
Additional Information: Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: ECMO, heart transplantation, pacemaker implantation, registry, pacemaker implantation, heart transplantation, registry, ECMO, 1103 Clinical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Clin Med
ISSN: 2077-0383
Language: eng
Dates:
DateEvent
17 February 2023Published
10 February 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 36836136
Web of Science ID: WOS:000939128400001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115311
Publisher's version: https://doi.org/10.3390/jcm12041604

Actions (login required)

Edit Item Edit Item